ERBB2 and breast cancer: Together, these results in Figures 5–7 support a role for mTOR in lipid synthesis and utilization particularly in the HER2/PIK3CA-hyperactive breast cancer cells, which contribute to the antitumor efficacy of mTOR-targeted therapy.